Aura Biosciences (AURA) Other Gross PP&E Adjustments (2020 - 2026)
Aura Biosciences filings provide 7 years of Other Gross PP&E Adjustments readings, the most recent being -$6.0 million for Q1 2026.
- Quarterly Other Gross PP&E Adjustments rose 21.47% to -$6.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$6.0 million through Mar 2026, up 21.47% year-over-year, with the annual reading at -$6.5 million for FY2025, 38.93% up from the prior year.
- Other Gross PP&E Adjustments hit -$6.0 million in Q1 2026 for Aura Biosciences, up from -$6.5 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $8.1 million in Q2 2022 and bottomed at -$23.5 million in Q1 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$8.5 million, with a median of -$9.2 million recorded in 2024.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 404.62% in 2023 before it skyrocketed 57.04% in 2024.
- Aura Biosciences' Other Gross PP&E Adjustments stood at -$12.7 million in 2022, then decreased by 0.84% to -$12.8 million in 2023, then increased by 16.83% to -$10.6 million in 2024, then surged by 38.93% to -$6.5 million in 2025, then rose by 7.84% to -$6.0 million in 2026.
- Per Business Quant, the three most recent readings for AURA's Other Gross PP&E Adjustments are -$6.0 million (Q1 2026), -$6.5 million (Q4 2025), and -$6.8 million (Q3 2025).